Multiparametric Magnetic Resonance Imaging (mpMRI), including diffusion-weighted imaging (DWI), plays a key role in detecting and stratifying prostate cancer (PCa). The Apparent Diffusion Coefficient (ADC) aids in tissue characterization and may assist in distinguishing between Gleason score 7 subgroups (GS 3 +4 and GS 4 +3). This study aimed to evaluate mean ADC and ADCratio (ratio of tumor-to-normal ADC) in differentiating these subgroups and to assess the influence of magnetic field strength (1.5 T vs. 3.0 T) on diagnostic performance. This retrospective study included 48 patients with histologically confirmed GS 7 PCa who underwent mpMRI at 1.5 T or 3.0 T. Two experienced radiologists independently and blindly delineated tumor and reference ROIs. Inter-observer agreement was evaluated using the intraclass correlation coefficient (ICC). Correlation, t-tests, and receiver operating characteristic (ROC) analyses were used to assess relationships, group differences, and optimal cut-off values. Excellent inter-observer agreement was found for both mean ADC and ADCratio (ICC0.9). At 3.0 T, mean ADC (10.9 ×10⁻⁴ mm²/s vs 8.55 ×10⁻⁴ mm²/s, p = 0.011) and ADCratio (0.68 vs 0.54, p = 0.003) significantly distinguished GS 3 + 4 from GS 4 + 3, while no differences were observed at 1.5 T. Spearman’s ρ confirmed stronger correlations at 3.0 T (ADCratio ρ=−0.510; p = 0.004). For the combined (3.0 T + 1.5 T) dataset, ADCratio achieved an AUC of 0.748 and mean ADC an AUC of 0.718 (p > 0.05). ADCratio demonstrated high reproducibility and stable diagnostic performance across scanners, supporting its potential as a reliable imaging biomarker for prostate cancer grading.
Background/Objectives: Radiomics enables extraction of quantitative imaging features to support non-invasive classification of prostate cancer (PCa). Accurate detection of clinically significant PCa (csPCa; Gleason score ≥ 3 + 4) is crucial for guiding treatment decisions. However, many studies explore limited feature selection, classifier, and harmonization combinations, and lack external validation. We aimed to systematically benchmark modeling pipelines and evaluate whether combining radiomics with the lesion-to-normal ADC ratio improves classification robustness and generalizability in multicenter datasets. Methods: Radiomic features were extracted from ADC maps using IBSI-compliant pipelines. Over 100 model configurations were tested, combining eight feature selection methods, fifteen classifiers, and two harmonization strategies across two scenarios: (1) repeated cross-validation on a multicenter dataset and (2) nested cross-validation with external testing on the PROSTATEx dataset. The ADC ratio was defined as the mean lesion ADC divided by contralateral normal tissue ADC, by placing two identical ROIs in each side, enabling patient-specific normalization. Results: In Scenario 1, the best model combined radiomics, ADC ratio, LASSO, and Naïve Bayes (AUC-PR = 0.844 ± 0.040). In Scenario 2, the top-performing configuration used Recursive Feature Elimination (RFE) and Boosted GLM (a generalized linear model trained with boosting), generalizing well to the external set (AUC-PR = 0.722; F1 = 0.741). ComBat harmonization improved calibration but not external discrimination. Frequently selected features were texture-based (GLCM, GLSZM) from wavelet- and LoG-filtered ADC maps. Conclusions: Integrating radiomics with the ADC ratio improves csPCa classification and enhances generalizability, supporting its potential role as a robust, clinically interpretable imaging biomarker in multicenter MRI studies.
Background/Objectives: Single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) is widely used for non-invasive assessment of coronary artery disease under stress and rest conditions. Although deep learning has shown promise for automated SPECT MPI interpretation, most studies focus on single-tracer datasets and do not explicitly account for tracer-dependent variability. This study developed and evaluated a multi-task deep learning framework with tracer-specific prediction heads for patient-level SPECT MPI classification. Methods: A convolutional neural network with a shared feature encoder and tracer-specific heads was implemented using polar map representations from technetium-99m (Tc-99m) and thallium-201 (Tl-201) studies. Transfer learning from ImageNet was applied. Stress-only, rest-only, and dual-input configurations were evaluated using repeated patient-stratified cross-validation and independent testing. Performance was assessed using ROC-AUC and balanced accuracy. Results: For Tc-99m normal versus abnormal perfusion classification, the stress-only model achieved the highest cross-validation AUC (0.88 ± 0.067) and test AUC of 0.88 [0.67–0.99]. For Tl-201 low-risk versus intermediate/high-risk classification, stress-based models achieved the highest cross-validation AUC (0.88 ± 0.051) and test AUC of 0.80 [0.71–0.89], comparable to dual-input models. In both tracer-specific tasks, stress-phase information showed favorable performance, but the endpoints differed and should be interpreted separately. Conclusions: Stress-phase polar maps provided strong discriminative information within this single-center cohort. These findings should be interpreted in a tracer- and task-specific manner supporting stress-phase imaging as an informative input for AI-based SPECT MPI classification while underscoring the need for external validation before broader clinical generalization.